Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Molecular Biosciences|December 10, 2021
Mitochondrial Dysfunction in Advanced Liver Disease: Emerging ConceptsIngrid W Zhang, Cristina López-Vicario, Marta Duran-Güell, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|August 5, 2021
Proresolving lipid mediators and liver diseaseJoan Clària, Roger Flores-Costa, Marta Duran-Güell, et al.
Hepatology Communications|February 18, 2022
Albumin Lipidomics Reveals Meaningful Compositional Changes in Advanced Cirrhosis and Its Potential to Promote Inflammation ResolutionMireia Casulleras, Roger Flores-Costa, Marta Duran-Güell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 4, 2017
The specialized proresolving lipid mediator maresin 1 protects hepatocytes from lipotoxic and hypoxia-induced endoplasmic reticulum stressBibiana Rius, Marta Duran-Güell, Roger Flores-Costa, et al.
Hepatology (Baltimore, Md.)|May 1, 2026
The linoleic acid-derived leukotoxin 9,10-DiHOME drives immunosuppression in patients with acute-on-chronic liver failureBryan J Contreras, Berta Romero-Grimaldo, María Belén Sánchez-Rodríguez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 26, 2021
Albumin protects the liver from tumor necrosis factor α-induced immunopathologyMarta Duran-Güell, Roger Flores-Costa, Mireia Casulleras, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2020
Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuitRoger Flores-Costa, Marta Duran-Güell, Mireia Casulleras, et al.
Hepatology (Baltimore, Md.)|July 5, 2022
Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction-associated fatty liver diseaseCristina López-Vicario, David Sebastián, Mireia Casulleras, et al.
British Journal of Pharmacology|December 28, 2017
The soluble guanylate cyclase stimulator IW-1973 prevents inflammation and fibrosis in experimental non-alcoholic steatohepatitisRoger Flores-Costa, José Alcaraz-Quiles, Esther Titos, et al.
Pageof 2